BioNTech Stock Pops on Big Sales Beat
Shares of BioNTech (NASDAQ:BNTX) are up around 1.5% in pre-open Monday after the biotech company reported better-than-expected Q1 EPS and revenue. The German biotechnology company...
Neutral
or
Shanghai Fosun Pharm News & Analysis
-
-
Shares of China vaccine makers slump on U.S. waiver support
SHANGHAI, May 6 (Reuters) - Shares in Chinese vaccine makers slumped on Thursday after U.S. President Joe Biden's support for a proposed waiver of intellectual property rights on COVID-19...
-
BRIEF-Shanghai Fosun Pharmaceutical's 2020 Net Profit Up 10.3% Y/Y
March 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS 2196.HK :* SAYS 2020 NET PROFIT UP 10.3% Y/Y* SAYS IT AUTHORISE UNIT GLAND PHARMA TO INVEST IN MUTUAL FUNDS AND...
-
UPDATE 2-India's Gland Pharma jumps 23% in market debut
(Adds book runners, analyst quote)By Anuron Kumar MitraBENGALURU, Nov 20 (Reuters) - Shares of India's Gland Pharma GLAD.NS got off to a flying start in their market debut on Friday,...
-
CORRECTED-India's Gland Pharma jumps 20% in market debut
(Corrects amount raised in IPO to "64.80 billion rupees" from "73.87 billion rupees" in paragraph 1)BENGALURU, Nov 20 (Reuters) - Shares of India's Gland Pharma GLAD.NS rose as much as 20%...
-
How Pfizer vaccine could be cold comfort for some Asian nations
By Rocky Swift, Sangmi Cha and Neil Jerome MoralesTOKYO/SEOUL/MANILA, Nov 10 (Reuters) - With tropical heat, remote island communities and a dearth of ultra-cold freezers, many Asian...
-
Could India-China Tensions be Behind Gland Pharma’s Tepid IPO Response?
By Aditya Raghunath Investing.com -- India’s largest pharma IPO (initial public offering) received a very tepid response on day 1 as retail investors only subscribed 1.4% of the total...
-
BRIEF-Shanghai Fosun Pharma's Unit Gland Pharma Plans Listing In India's NSE And Bombay Stock Exchange
Nov 1 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 2196.HK 600196.SS :* SAYS UNIT GLAND PHARMA LTD PLANS LISTING IN INDIA'S NSE AND BOMBAY STOCK EXCHANGE
-
China shares higher at close of trade; Shanghai Composite up 1.89%
Investing.com – China equities were higher at the close on Monday, as gains in the Travel & Leisure, Real Estate Investments & Services and Technology Hardware & Equipment sectors propelled...
-
Deals of the day-Mergers and acquisitions
(Adds DP World, Walgreens Boots Alliance, Jollibee Foods , Ford Motor, Blackstone (NYSE:BX), Itron, Teva Pharmaceutical, Fir Tree Partners, Triton Knoll, Northrop Grumman ; Updates OHL ...
-
UPDATE 1-China's Fosun Pharma to buy smaller stake in Indian firm for $1.1bn
(Recasts, adds Gland Pharma comments, background) By Dominique Patton and Zeba Siddiqui BEIJING/MUMBAI, Sept 17 (Reuters) - Shanghai Fosun Pharmaceutical Group 600196.SS has agreed to cut...
-
China's Fosun Pharma to buy smaller stake in Indian pharma firm
BEIJING, Sept 17 (Reuters) - Shanghai Fosun Pharmaceutical Group 600196.SS has agreed to cut the size of the stake it will buy in India's Gland Pharma to 74 percent, the Chinese...
-
UPDATE 1-China-India border spat casts shadow ahead of BRICS summit
(Adds Indian statement in paragraphs 6-7) By Ben Blanchard BEIJING, Aug 3 (Reuters) - China is taking an increasingly tough line on a border row with India amid a rising crescendo of...
-
China-India border spat casts shadow ahead of BRICS summit
By Ben Blanchard BEIJING, Aug 3 (Reuters) - China is taking an increasingly tough line on a border row with India amid a rising crescendo of nationalism in state media, and President Xi...
-
UPDATE 1-India raises concerns around Chinese firm Fosun's takeover of Gland-source
* Deal has FIPB, CCI approval; CCEA nod pending * Fosun says closing date of deal extended to Sept. 26 (Releads to change source and add details) July 31 (Reuters) - India has privately...
-
BRIEF-Shanghai Fosun Pharmaceutical responds to media reports
March 30 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS : * Reference is made to announcements of Shanghai Fosun Pharmaceutical (Group) Co., dated 28 July 2016 *...
-
UPDATE 1-Buyout groups secure funding to pursue Stada bids
(Adds financing details) By Patricia Weiss and Claire Ruckin FRANKFURT/LONDON, March 15 (Reuters) - Two private equity consortia vying for control of German generic drugmaker Stada...
-
Buyout groups confirm Stada bids, secure funding - sources
By Patricia Weiss and Alexander Hübner FRANKFURT, March 15 (Reuters) - The two private equity consortia vying for Stada STAGn.DE have made binding takeover offers each worth 4.7...
-
UPDATE 1-China's Fosun Pharma set to join bidding for Germany's Stada - sources
(Writes through with context) By Arno Schuetze and Sumeet Chatterjee FRANKFURT/HONG KONG, March 9 (Reuters) - China's Shanghai Fosun Pharmaceutical 600196.SS is planning a bid for German...
-
Deals of the day-Mergers and acquisitions
( Adds Brookdale Senior Living and UBI; Updates Mitsubishi Rayon, Valeant Pharmaceuticals and American Apparel) Jan 10 (Reuters) - The following bids, mergers, acquisitions and disposals...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
